These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6313185)

  • 1. Cerebrospinal fluid GABA as an index of brain GABA activity.
    Grove J; Palfreyman MG; Schechter PJ
    Clin Neuropharmacol; 1983; 6(3):223-9. PubMed ID: 6313185
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid).
    Grove J; Schechter PJ; Tell G; Koch-Weser J; Sjoerdsma A; Warter JM; Marescaux C; Rumbach L
    Life Sci; 1981 May; 28(21):2431-9. PubMed ID: 6789022
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Pyrrolidinone in human cerebrospinal fluid: a major constituent of total gamma-aminobutyric acid.
    Haegele KD; Schwartz JJ; Schoun J; Schmitt AH; Schechter PJ
    J Neurochem; 1987 Nov; 49(5):1402-6. PubMed ID: 3668531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.
    Palfreyman MG; Huot S; Grove J
    Neurosci Lett; 1983 Feb; 35(2):161-6. PubMed ID: 6856194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
    Grove J; Schechter PJ; Hanke NF; de Smet Y; Agid Y; Tell G; Koch-Weser J
    J Neurochem; 1982 Dec; 39(6):1618-22. PubMed ID: 7142991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine.
    Grove J; Schechter PJ; Tell G; Rumbach L; Marescaux C; Warter JM; Koch-Weser J
    J Neurochem; 1982 Oct; 39(4):1061-5. PubMed ID: 7119781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment.
    Pitkänen A; Matilainen R; Ruutiainen T; Riekkinen P
    J Neurol Sci; 1988 Dec; 88(1-3):83-93. PubMed ID: 3225631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
    J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy.
    Menachem EB; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP
    Epilepsy Res; 1988; 2(2):96-101. PubMed ID: 3143561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentration of free amino acids and homocarnosine dipeptide in the cerebrospinal fluid of children with hydrocephalus].
    Bondarenko TI; Makletsova MG; Sukhomovskiĭ BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1484-8. PubMed ID: 6659780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
    Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C
    Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ; Ylinen A; Halonen T; Sivenius J; Pitkanen A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures.
    Ben Menachem E; Persson L; Schechter PJ; Haegele KD; Huebert N; Hardenberg J
    J Neurochem; 1989 Feb; 52(2):632-5. PubMed ID: 2463340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid GABA levels in chronic migraine with and without depression.
    Vieira DS; Naffah-Mazacoratti MG; Zukerman E; Senne Soares CA; Alonso EO; Faulhaber MH; Cavalheiro EA; Peres MF
    Brain Res; 2006 May; 1090(1):197-201. PubMed ID: 16638608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
    Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
    Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA in cerebrospinal fluid of children with febrile convulsions.
    Löscher W; Rating D; Siemes H
    Epilepsia; 1981 Dec; 22(6):697-702. PubMed ID: 6273149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of aging on cerebrospinal fluid GABA level].
    Kuroda H; Ogawa N; Nukina I; Ota Z
    Nihon Ronen Igakkai Zasshi; 1983 Nov; 20(6):500-5. PubMed ID: 6674631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.